A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
批准号:
10210424
负责人:
Julia Zeitlinger
金额:
$48.97万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-14 至 2023-06-30
关键词:
ATAC-seqAdultAutomationBar CodesBindingBiological AssayCellsChIP-seqChromatinCodeComplexDNADNA FragmentationDNA SequenceDataData AnalysesDevelopmentDiagnosticDigestionDiseaseEmbryoEvolutionExonucleaseGenetic TranscriptionGenomeGenomic LibraryGenomicsGoalsHumanIndividualLibrariesLigationMeasurementMeasuresMusMutationNucleotidesPatientsPreventive MedicineProtocols documentationPublic HealthResearchResolutionRoboticsSamplingSingle-Stranded DNASourceSystemTechnologyTimeTissuesTn5 transposaseTransposaseVariantWorkbasebiological systemscell typecombinatorialdesignembryonic stem cellexperimental studyhuman diseaseimprovedin vivoinnovationinsightinternal controlnew technologynovel strategiespluripotencytheoriestranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Predicting cis-regulatory information from sequence alone is not yet possible, but collecting cis-regulatory
information systematically across all human cell types and across species would be feasible with significant
progress in technology. Here we propose to develop such breakthrough technology that will allow to extract
cis-regulatory information from any cell type, including mixtures of heterogeneous cell types. The technology is
based on a transposase system that combines ChIP and ATAC-seq technology, and thus allows the
simultaneous measurement of chromatin accessibility and transcription factor occupancy in the same cells. It is
innovative in its orders of magnitude improvement in efficiency by which DNA fragments enter the genomic
library, which allows the assay to be performed at single-cell resolution. It is cutting-edge in its resolution,
which allows the identification of precise footprints of transcription factor bound in vivo. We will optimize scale
and workflow, as well as develop an initial analysis framework, to make the technology applicable to a wide
range of systems. As proof-of-principle, we will apply the technology to early mouse embryos and compare the
results to those obtained from mouse embryonic stem cells. Having such technology will open the door to
unprecedented explorations of cis-regulatory information across any cell type. It will deepen our understanding
of transcriptional regulatory networks during development and evolution, and will provide insights into
mutations and mechanisms underlying human disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.coisb.2020.08.002
发表时间:
2020-10
期刊:
Current opinion in systems biology
影响因子:
3.7
作者:
[Zeitlinger J]
通讯作者:
Zeitlinger J
海外基金